INTANGIBLE ASSETS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
INTANGIBLE ASSETS (Details Narrative) - USD ($)	Oct. 12, 2018	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Intangible assets, gross		$ 3,176,700		$ 3,176,700		$ 15,200
Accumulated amortization		164,867		$ 164,867		7,352
Naltrexone Implant Formulation [Member] \| Australia from Trinity Compound Solutions [Member]
Patent acquired	$ 15,200
Estimated useful lives	13 years			10 years
Customer Base [Member]
Intangible assets, gross		2,709,500		$ 2,709,500		0
Accumulated amortization		156,631		156,631
Amortization expense		68,294		156,631
Intellectual Property [Member]
Amortization expense		295	$ 295	884	$ 884
Accumulated amortization		8,236		8,236
Trademarks [Member]
Intangible assets, gross		$ 452,000		$ 452,000		$ 0